Rutgers Cancer Institute at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Rutgers Cancer Institute brings 2 presentations to ASH 2026 in New Orleans, and exhibits at Booth 1923. Its program centres on follicular and diffuse large B-cell lymphoma, including bispecific antibody regimens and molecular testing for diagnosis and prognosis. It also shares AI and social media tools that support medical teaching.
| Organization | ASH 2026 Attendance |
|---|---|
Rutgers Cancer Institute New Brunswick, NJ | |
New Jersey's NCI-designated comprehensive cancer center, run with RWJBarnabas Health, offering cell therapy, stem cell transplant and clinical trials. | Booth Exhibiting at Booth 1923 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 3:00pm–6:00pm Optimizing Integration of BsAb-Based Therapies for FL and DLBCL: Expert Perspectives on New Standards and Future Directions How bispecific antibodies for follicular and diffuse large B-cell lymphoma differ in structure, dosing, and safety, and how to sequence them in community care. |
Instantly find 20 buyers from Rutgers Cancer Institute
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction